The influence of exogenous lactoferrin on plasma levels of acute phase proteins in a dry immersion experiment

Authors

  • Olga N. Larina Institute of Biomedical Problems, Russian Academy of Sciences https://orcid.org/0000-0002-2827-3428
  • Anna M. Bekker Institute of Biomedical Problems, Russian Academy of Sciences
  • Galina Yu. Vasilieva Institute of Biomedical Problems, Russian Academy of Sciences https://orcid.org/0000-0003-0879-889X
  • Irina V. Kovachevich Institute of Biomedical Problems, Russian Academy of Sciences
  • Andrey M. Nosovsky Institute of Biomedical Problems, Russian Academy of Sciences
  • Elena R. Sadchikova Institute of Gene Biology, Russian Academy of Sciences https://orcid.org/0000-0003-2039-7108

DOI:

https://doi.org/10.33910/2687-1270-2026-7-1-121-133

Keywords:

dry immersion, weightlessness, human, lactoferrin, acute phase reactants

Abstract

Lactoferrin (LF) is a multifunctional protein with antimicrobial, anti-inflammatory, and antioxidant properties. It is used as a food additive and as a food ingredient to extend shelf life. LF synthesis is localized in epithelial tissues and innate immune cells. In neutrophils, lactoferrin is concentrated in secondary granules, which release their contents upon neutrophil activation. Extreme conditions can induce adaptive changes affecting the innate immune system, which responds by activating inflammatory mechanisms. One such adaptive process is the acute phase response (APR). In a dry immersion experiment simulating the effects of weightlessness on the body, the influence of LF supplementation on APR development was studied. A five-day immersion study was conducted on 21 female subjects divided into three groups. Subjects in the LF1 and LF2 groups received LF daily at doses of 200 mg and 400 mg, respectively, while the placebo group received no LF. Concentrations of the acute phase proteins haptoglobin (Hp), α1-acid glycoprotein (α1-AGP), and α1-antitrypsin (α-AT) were measured in blood plasma. The effect of lactoferrin was most pronounced at the beginning of immersion period. LF at a dose of 200 mg/day stimulated plasma protein synthesis on the first day of the experiment. At a dose of 400 mg/day, most subjects showed a decrease in α-AT concentrations, which may be attributable to neutrophil degranulation and the release of excess amounts of elastase into the bloodstream. The results indicate that lactoferrin administered as a dietary supplement during immersion influences the balance of plasma proteins in a dose-dependent manner.

References

Aleshina, G. M. (2019) Lactoferrin — an endogenous regulator of the protective functions of the organism. Medical Academic Journal, vol. 19, no. 1, pp. 35–44. https://doi.org/10.17816/MAJ19135-44 (In Russian)

Ceciliani, F., Giordano, A., Spagnolo, V. (2002) The systemic reaction during inflmmation: The acute-phase proteins. Protein & Peptide Letters, vol. 9, no. 3, pp. 211–223. https://doi.org/10.2174/0929866023408779 (In English)

de la Rosa, G., Yang, D., Tewary, P. et al. (2008) Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. The Journal of Immunology, vol. 180, no. 10, pp. 6868–6876. https://doi.org/10.4049/jimmunol.180.10.6868 (In English)

Duran, A., Kahve, H. I. (2017) The use of lactoferrin in food industry. Academic Journal of Science, vol. 7, no. 2, pp. 89–94. (In English)

Fritz, H. (1980) Proteinase inhibitors in severe inflammatory processes (septic shock and experimental endotoxaemia): Biochemical, pathophysiological and therapeutic aspects. In: D. Evered, J. Whelan (eds.). Ciba Foundation Symposium 75 — Protein Degradation in Health and Disease. [S. l.]: Excerpta Medica Publ., pp. 351–379. https://doi.org/10.1002/9780470720585.ch20 (In English)

Hwang, S.-A., Wilk, K. M., Bangale, Y. A. et al. (2007) Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Medical Microbiology and Immunology, vol. 196, pp. 171–180. https://doi.org/10.1007/s00430-007-0041-6 (In English)

Kruzel, M. L., Harari, Y., Mailman, D. et al. (2002) Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clinical and Experimental Immunology, vol. 130, no. 1, pp. 25–31. https://doi.org/10.1046/j.1365-2249.2002.01956.x (In English)

Kruzel, M. L., Zimecki, M., Actor, J. K. (2017) Lactoferrin in a context of inflammation-induced pathology. Frontiers in Immunology, vol. 8, article 1438. https://doi.org/10.3389/fimu.2017.01438 (In English)

Larina, O. N., Bekker, A. M., Tyurin-Kuzmin, A. Yu. (2024) Exposure to extreme factors causes activation of the mechanisms of acute phase response. In: Proceedings of All-Russian Scientific and Practical Conference with International Participation “The Teachings of Academician I. P. Pavlov in the Modern System of Neurosciences,” dedicated to the 175th anniversary of the birth of Academician I. P. Pavlov and the 120th anniversary of his Nobel Prize. Saint Petersburg: Institute of Experimental Medicine Publ., pp. 488–489. (In Russian)

Larina, O. N., Bekker, A. M., Vasilieva, G. Yu. et al. (2025) Lactoferrin reduces ceruloplasmin plasma levels under conditions simulating weightlessness in humans. Integrative Physiology, vol. 6, no. 2, pp. 171–180. https://doi.org/10.33910/2687-1270-2025-6-2-171-180 (In Russian)

Law, R. H., Zhang, Q., McGowan, S. et al. (2006) An overview of the serpin superfamily. Genome Biology, vol. 7, аrticle 216. https://doi.org/10.1186/gb-2006-7-5-216 (In English)

Machnicki, M., Zimecki, M., Zagulski, T. (1993) Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. International Journal of Experimental Pathology, vol. 74, no. 5, pp. 433–439. (In English)

Moradzadeh, M., Sargazi, N., Pourasgari, M. et al. (2020) Increasing neutrophil elastase and decreasing its inhibitor, alpha 1-antitrypsin, in patients with non-alcoholic fatty liver disease. Hepatitis monthly, vol. 20, no. 1, article e99735. https://doi.org/10.5812/hepatmon.99735 (In English)

Nakamura, A., Kimura, F., Tsuji, S. et al. (2022) Bovine lactoferrin suppresses inflammatory cytokine expression in endometrial stromal cells in chronic endometritis. Journal of Reproductive Immunology, vol. 154, article 103761. https://doi.org/10.1016/j.jri.2022.103761 (In English)

Ogasawara, Y., Imase, M., Oda, H. et al. (2014) Lactoferrin directly scavenges hydroxyl radicals and undergoes oxidative self-degradation: A possible role in protection against oxidative DNA damage. International Journal of Molecular Sciences, vol. 15, no. 1, pp. 1003–1013. (In English)

Shimi, G., Sohrab, G., Pourvali, K. et al. (2021) Correlation of low levels of α-1 antitrypsin and elevation of neutrophil to lymphocyte ratio with higher mortality in severe COVID-19 patients. Mediators of Inflammation, vol. 2021, article 5555619. https://doi.org/10.1155/2021/5555619 (In English)

Sorimachi, K., Akimoto, K., Hattori, Y. et al. (1997) Activation of macrophages by lactoferrin: Secretion of TNF-alpha, IL-8 and NO. IUBMB Life, vol. 43, no. 1, pp. 79–87. https://doi.org/10.1080/15216549700203841 (In English)

Suzuki, Y. A., Lopez, V., Lönnerdal, B. (2005) Mammalian lactoferrin receptors: Structure and function. Cellular and Molecular Life Sciences, vol. 62, pp. 2560–2575. https://doi.org/10.1007/s00018-005-5371-1 (In English)

Yami, H. A., Tahmoorespur, M., Javadmanesh, A. et al. (2023) The immunomodulatory effects of lactoferrin and its derived peptides on NF-κB signaling pathway: A systematic review and meta-analysis. Immunity, Inflammation and Disease, vol. 11, no. 8, article e972. https://doi.org/10.1002/iid3.972 (In English)

Published

2026-05-20

Issue

Section

Experimental articles